Raltegravir

CAS No. 518048-05-0

Raltegravir ( MK-0518;MK 0518;MK0518 )

Catalog No. M14807 CAS No. 518048-05-0

A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 34 In Stock
5MG 52 In Stock
10MG 95 In Stock
25MG 173 In Stock
50MG 286 In Stock
100MG 426 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Raltegravir
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.
  • Description
    A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM; essentially inactive (IC50s>50 uM) against HCV Pol, HIV RT, HIV RNase-H, and human α/β/γ Pol; shows inhibitory activity against the wild type virus and a selection of mutants; the first HIV-integrase inhibitor for the treatment of HIV-1 infection.HIV Infection Approved
  • Synonyms
    MK-0518;MK 0518;MK0518
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    Integrase(S217QPFV);Integrase(WTPFV)
  • Research Area
    Infection
  • Indication
    HIV Infection

Chemical Information

  • CAS Number
    518048-05-0
  • Formula Weight
    444.42
  • Molecular Formula
    C20H21FN6O5
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F
  • Chemical Name
    4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Summa V, et al. J Med Chem. 2008 Sep 25;51(18):5843-55.
2. Malet I, et al. Antimicrob Agents Chemother. 2008 Apr;52(4):1351-8.
3. Cooper DA, et al. N Engl J Med. 2008 Jul 24;359(4):355-65.
molnova catalog
related products
  • CHLOROQUINE

    Chloroquine is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis.

  • DRB

    DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II (IC50 range of 4-10 μM).

  • Bictegravir

    Bictegravir (GS 9883) is a novel potent HIV-1 integrase (IN) that specifically targets IN strand transfer activity with IC50 of 7.5 nM.